Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 7.0
(-2.51%)
CNY 7.0
(-2.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 173.35 Million CNY | -44.14% |
| 2022 | 242.3 Million CNY | -38.27% |
| 2021 | 494.22 Million CNY | -2.04% |
| 2020 | 517.96 Million CNY | 56.0% |
| 2019 | 665.99 Million CNY | 65.59% |
| 2018 | 238.4 Million CNY | 70.01% |
| 2017 | 171.22 Million CNY | -1.01% |
| 2016 | 137.12 Million CNY | -5.23% |
| 2015 | 144.27 Million CNY | -24.57% |
| 2014 | 193.13 Million CNY | -7.49% |
| 2013 | 215.68 Million CNY | 8.0% |
| 2012 | 194.5 Million CNY | -26.6% |
| 2011 | 271.69 Million CNY | 5.6% |
| 2010 | 256.36 Million CNY | 23.77% |
| 2009 | 207.02 Million CNY | 31.55% |
| 2008 | 155.16 Million CNY | 13.0% |
| 2007 | 139.32 Million CNY | 32.0% |
| 2006 | 106.11 Million CNY | 87.05% |
| 2005 | 56.72 Million CNY | -3.12% |
| 2004 | 58.55 Million CNY | 26.57% |
| 2003 | 46.26 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 5.95 Million CNY | 168.99% |
| 2024 Q2 | -3.09 Million CNY | -112.61% |
| 2024 Q1 | 53.85 Million CNY | -20.42% |
| 2023 Q1 | 38.73 Million CNY | -2.52% |
| 2023 Q2 | 3.14 Million CNY | -91.89% |
| 2023 Q3 | -14.72 Million CNY | -568.56% |
| 2023 Q4 | 85.42 Million CNY | 680.15% |
| 2023 FY | - CNY | -44.14% |
| 2022 Q2 | 66.4 Million CNY | 136.97% |
| 2022 FY | - CNY | -38.27% |
| 2022 Q3 | 133.89 Million CNY | 101.63% |
| 2022 Q4 | 39.73 Million CNY | -70.32% |
| 2022 Q1 | 28.02 Million CNY | -91.18% |
| 2021 FY | - CNY | -2.04% |
| 2021 Q1 | 41.6 Million CNY | -67.93% |
| 2021 Q2 | 268.49 Million CNY | 545.34% |
| 2021 Q3 | -115.02 Million CNY | -142.84% |
| 2021 Q4 | 317.6 Million CNY | 376.13% |
| 2020 Q3 | 190.83 Million CNY | 97.19% |
| 2020 Q4 | 129.73 Million CNY | -32.02% |
| 2020 Q1 | 88.38 Million CNY | -29.46% |
| 2020 Q2 | 96.77 Million CNY | 9.5% |
| 2020 FY | - CNY | 56.0% |
| 2019 Q4 | 125.29 Million CNY | 65.58% |
| 2019 Q1 | 36.25 Million CNY | -37.65% |
| 2019 Q2 | 74.9 Million CNY | 106.59% |
| 2019 Q3 | 75.66 Million CNY | 1.01% |
| 2019 FY | - CNY | 65.59% |
| 2018 Q3 | 44.08 Million CNY | -10.85% |
| 2018 Q4 | 58.15 Million CNY | 31.92% |
| 2018 FY | - CNY | 70.01% |
| 2018 Q1 | 18.49 Million CNY | -4.52% |
| 2018 Q2 | 49.44 Million CNY | 167.41% |
| 2017 Q3 | 35.24 Million CNY | 60.42% |
| 2017 Q2 | 21.96 Million CNY | 37.44% |
| 2017 Q1 | 15.98 Million CNY | 16.41% |
| 2017 FY | - CNY | -1.01% |
| 2017 Q4 | 19.36 Million CNY | -45.05% |
| 2016 Q1 | 18.87 Million CNY | 305.29% |
| 2016 FY | - CNY | -5.23% |
| 2016 Q4 | 13.73 Million CNY | -42.86% |
| 2016 Q3 | 24.03 Million CNY | -22.14% |
| 2016 Q2 | 30.86 Million CNY | 63.51% |
| 2015 Q4 | -9.19 Million CNY | -127.01% |
| 2015 Q1 | 23.01 Million CNY | -28.5% |
| 2015 FY | - CNY | -24.57% |
| 2015 Q2 | 40.84 Million CNY | 77.42% |
| 2015 Q3 | 34.04 Million CNY | -16.64% |
| 2014 FY | - CNY | -7.49% |
| 2014 Q3 | 38.15 Million CNY | -0.08% |
| 2014 Q1 | 31.88 Million CNY | -4.83% |
| 2014 Q4 | 32.19 Million CNY | -15.61% |
| 2014 Q2 | 38.18 Million CNY | 19.75% |
| 2013 Q3 | 34.96 Million CNY | -1.59% |
| 2013 Q1 | 42.95 Million CNY | 67.2% |
| 2013 Q2 | 35.53 Million CNY | -17.29% |
| 2013 Q4 | 33.5 Million CNY | -4.18% |
| 2013 FY | - CNY | 8.0% |
| 2012 FY | - CNY | -26.6% |
| 2012 Q3 | 35.06 Million CNY | -6.78% |
| 2012 Q2 | 37.61 Million CNY | -2.55% |
| 2012 Q1 | 38.6 Million CNY | 58.72% |
| 2012 Q4 | 25.69 Million CNY | -26.73% |
| 2011 Q1 | 56.62 Million CNY | 19.05% |
| 2011 FY | - CNY | 5.6% |
| 2011 Q2 | 65.98 Million CNY | 16.53% |
| 2011 Q4 | 24.32 Million CNY | -63.71% |
| 2011 Q3 | 67.01 Million CNY | 1.56% |
| 2010 Q2 | 46.04 Million CNY | 4.45% |
| 2010 Q4 | 47.56 Million CNY | -25.71% |
| 2010 Q1 | 44.08 Million CNY | 5.72% |
| 2010 Q3 | 64.02 Million CNY | 39.07% |
| 2010 FY | - CNY | 23.77% |
| 2009 FY | - CNY | 31.55% |
| 2009 Q4 | 41.69 Million CNY | -26.31% |
| 2009 Q3 | 56.58 Million CNY | 34.47% |
| 2009 Q2 | 42.07 Million CNY | 120.18% |
| 2009 Q1 | 19.11 Million CNY | 10.34% |
| 2008 FY | - CNY | 13.0% |
| 2008 Q3 | 41.24 Million CNY | 18.35% |
| 2008 Q1 | 29.05 Million CNY | -6.08% |
| 2008 Q2 | 34.84 Million CNY | 19.92% |
| 2008 Q4 | 17.31 Million CNY | -58.01% |
| 2007 Q2 | 26.49 Million CNY | 52.04% |
| 2007 Q4 | 30.93 Million CNY | -3.56% |
| 2007 Q1 | 17.42 Million CNY | -33.79% |
| 2007 FY | - CNY | 32.0% |
| 2007 Q3 | 32.08 Million CNY | 21.09% |
| 2006 Q4 | 26.31 Million CNY | 23.56% |
| 2006 Q3 | 21.3 Million CNY | -2.94% |
| 2006 Q2 | 21.94 Million CNY | 140.32% |
| 2006 Q1 | 9.13 Million CNY | -23.65% |
| 2006 FY | - CNY | 87.05% |
| 2005 Q3 | 8.21 Million CNY | 0.0% |
| 2005 Q4 | 11.96 Million CNY | 45.63% |
| 2005 FY | - CNY | -3.12% |
| 2004 FY | - CNY | 26.57% |
| 2003 FY | - CNY | 0.0% |